Destructive bronchiolitis: a characteristic pathological feature of interstitial lung disease preceding the onset of rheumatoid arthritis

M. Sato (Yokohama, Japan), E. Tabata (Yokohama, Japan), T. Takemura (Yokohama, Japan), T. Yamaya (Yokohama, Japan), M. Asaoka (Yokohama, Japan), T. Katano (Yokohama, Japan), K. Higa (Yokohama, Japan), Y. Sato (Yokohama, Japan), K. Uchida (Yokohama, Japan), R. Otoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), H. Okabayashi (Yokohama, Japan), S. Ikeda (Yokohama, Japan), T. Niwa (Yokohama, Japan), T. Oda (Yokohama, Japan), R. Okuda (Yokohama, Japan), A. Sekine (Yokohama, Japan), H. Kitamura (Yokohama, Japan), T. Baba (Yokohama, Japan), S. Komatsu (Yokohama, Japan), E. Hagiwara (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Ogura (Yokohama, Japan)

Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Sato (Yokohama, Japan), E. Tabata (Yokohama, Japan), T. Takemura (Yokohama, Japan), T. Yamaya (Yokohama, Japan), M. Asaoka (Yokohama, Japan), T. Katano (Yokohama, Japan), K. Higa (Yokohama, Japan), Y. Sato (Yokohama, Japan), K. Uchida (Yokohama, Japan), R. Otoshi (Yokohama, Japan), R. Shintani (Yokohama, Japan), H. Okabayashi (Yokohama, Japan), S. Ikeda (Yokohama, Japan), T. Niwa (Yokohama, Japan), T. Oda (Yokohama, Japan), R. Okuda (Yokohama, Japan), A. Sekine (Yokohama, Japan), H. Kitamura (Yokohama, Japan), T. Baba (Yokohama, Japan), S. Komatsu (Yokohama, Japan), E. Hagiwara (Yokohama, Japan), T. Iwasawa (Yokohama, Japan), T. Ogura (Yokohama, Japan). Destructive bronchiolitis: a characteristic pathological feature of interstitial lung disease preceding the onset of rheumatoid arthritis. 793

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome
Source: Eur Respir J 2011; 37: 1411-1417
Year: 2011



Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA)
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019


Characteristics and predictors of outcome in rheumatoid arthritis related ILD
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018
Year: 2019



Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Methotrexate and rheumatoid arthritis associated interstitial lung disease
Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020
Year: 2021



Comparison between patients with idiopathic pulmonary fibrosis and patients with pulmonary involvement of the usual interstitial pneumonia pattern that preceded the onset of rheumatoid arthritis
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Characterisation of severe obliterative bronchiolitis in rheumatoid arthritis
Source: Eur Respir J 2009; 33: 1053-1061
Year: 2009



Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Year: 2021



Drug-induced lung disease in rheumatoid arthritis: critical review of patterns
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009

Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Source: Eur Respir J 2010; 35: 1322-1328
Year: 2010



Rheumatoid arthritis-associated interstitial lung disease: time trends
Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes
Year: 2021



Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
Source: Breathe, 16 (4) 200223; 10.1183/20734735.0223-2020
Year: 2020



Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016

Idiopathic nonspecific interstitial pneumonia: an interstitial lung disease associated with autoimmune disorders?
Source: Eur Respir J 2011; 38: 384-391
Year: 2011